Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 391 participants.
Also called NCT00930436
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 391 participants
- Sponsor
- MD Scientific
- Registry
-
NCT00930436
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT00930436. Randomized; quadruple masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2012-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
- Acronym
- BOSS
- Condition
- Contrast Induced Kidney Injury.
- Intervention (Drug)
- sodium bicarbonate
- Lead sponsor
- MD Scientific
Record details
- Record id
cardio:ct-nct00930436- Content hash
a15cf6b2f105a1fc4b9c0f189935ae4b20aea90c056465529ae37dd6fe9bd211